MMP9 and cystic fibrosis: In the IFN-β-treated CF, the co-culture between CF and neutrophils a reduced MMP9 activity respect unstimulated CF was observed (denoted as black bars# in the graph), and these effects was not modified by JAK inhibition with ruxolitinib.